Advisory Services Network’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-30
| Closed | -$135 | – | 3730 |
|
|
2026
Q1 | $135 | Buy |
+30
| New | +$156 | ﹤0.01% | 4633 |
|
|
2025
Q4 | – | Sell |
-18
| Closed | -$130 | – | 3371 |
|
|
2025
Q3 | $130 | Buy |
+18
| New | +$107 | ﹤0.01% | 4290 |
|
|
2021
Q1 | – | Sell |
-250
| Closed | -$5K | – | 2356 |
|
|
2020
Q4 | $5K | Sell |
250
-283
| -53% | -$4.57K | ﹤0.01% | 2720 |
|
|
2020
Q3 | $7K | Buy |
+533
| New | +$6.75K | ﹤0.01% | 2637 |
|
|
2020
Q2 | – | Sell |
-1,083
| Closed | -$15K | – | 2112 |
|
|
2020
Q1 | $15K | Hold |
1,083
| – | – | ﹤0.01% | 2034 |
|
|
2019
Q4 | $29K | Buy |
1,083
+553
| +104% | +$15.2K | ﹤0.01% | 1817 |
|
|
2019
Q3 | $15K | Hold |
530
| – | – | ﹤0.01% | 1969 |
|
|
2019
Q2 | $15K | Buy |
530
+280
| +112% | +$7.91K | ﹤0.01% | 1967 |
|
|
2019
Q1 | $8K | Hold |
250
| – | – | ﹤0.01% | 1938 |
|
|
2018
Q4 | $7K | Hold |
250
| – | – | ﹤0.01% | 1903 |
|
|
2018
Q3 | $12K | Sell |
250
-540
| -68% | -$24K | ﹤0.01% | 1763 |
|
|
2018
Q2 | $34K | Sell |
790
-200
| -20% | -$6.75K | ﹤0.01% | 1347 |
|
|
2018
Q1 | $29K | Hold |
990
| – | – | ﹤0.01% | 1511 |
|
|
2017
Q4 | $34K | Hold |
990
| – | – | ﹤0.01% | 1430 |
|
|
2017
Q3 | $36K | Sell |
990
-500
| -34% | -$14.3K | ﹤0.01% | 1222 |
|
|
2017
Q2 | $39K | Sell |
1,490
-200
| -12% | -$4.25K | 0.01% | 1127 |
|
|
2017
Q1 | $32K | Buy |
+1,690
| New | +$29.9K | ﹤0.01% | 1122 |
|
|
2016
Q3 | $208K | Sell |
10,115
-9,485
| -48% | -$241K | 0.04% | 487 |
|
|
2016
Q2 | $600K | Buy |
19,600
+1,395
| +8% | +$48.5K | 0.14% | 209 |
|
|
2016
Q1 | $681K | Buy |
18,205
+1,416
| +8% | +$53.4K | 0.19% | 144 |
|
|
2015
Q4 | $725K | Buy |
16,789
+774
| +5% | +$32.7K | 0.23% | 107 |
|
|
2015
Q3 | $600K | Buy |
16,015
+2,370
| +17% | +$84.1K | 0.18% | 122 |
|
|
2015
Q2 | $469K | Buy |
13,645
+1,300
| +11% | +$44.2K | 0.14% | 163 |
|
|
2015
Q1 | $433K | Buy |
12,345
+1,125
| +10% | +$40.3K | 0.12% | 190 |
|
|
2014
Q4 | $426K | Buy |
11,220
+2,575
| +30% | +$91.4K | 0.13% | 167 |
|
|
2014
Q3 | $333K | Buy |
+8,645
| New | +$323K | 0.12% | 188 |
|
Other funds holding MYGN
VPC
Advisory Services Network's MYGN Position: Q2 2026 in Review
Advisory Services Network sold out of Myriad Genetics (MYGN) in Q2 2026, closing a stake of 30 shares — an estimated $135 sold.
Advisory Services Network first reported a position in MYGN in Q3 2014 and held it in 26 quarters. The position peaked at $725K in Q4 2015. 197 funds tracked by Wall St. Rank hold MYGN as of Q2 2026.
- Advisory Services Network reported no remaining Myriad Genetics position as of Q2 2026 after selling out during the quarter.
- Advisory Services Network sold 30 Myriad Genetics shares in Q2 2026, an estimated $135.
- Advisory Services Network first reported a position in Myriad Genetics in Q3 2014 and held it in 26 quarters.
- Advisory Services Network's Myriad Genetics position peaked at $725K in Q4 2015.
- 197 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2026.
Based on Advisory Services Network's 13F filing for Q2 2026, filed 12 Aug 2026.